Brief: Vascular Biogenics Posts Q2 Revenue Of $188,000

Notable Labs

16/08/2021 12:22

Aug 16 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VBL THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q2 REVENUE $188,000
    * Q2 REVENUE ESTIMATE $325,000 -- REFINITIV IBES DATA
    * QTRLY LOSS PER SHARE $0.12
    * Q2 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX987yJj 
Further company coverage:  VBLT.O 

 (((Reuters.Briefs@thomsonreuters.com);))